Reading time: 8 minutes Alex DeWalle At the core of translational oncology lies a fundamental problem: how do we kill tumor cells without harming healthy tissue? Novel therapies must directly target tumor cells to achieve this goal in a way that traditional chemotherapies cannot. CAR T-cell therapy (CAR T) is one of the most promising... Continue Reading →